M&A Deal Summary |
|
|---|---|
| Date | 2002-06-13 |
| Target | Enteric Medical Technologies |
| Sector | Life Science |
| Buyer(s) | Boston Scientific |
| Sellers(s) | Montreux Equity Partners |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1979 |
| Sector | Medical Products |
| Employees | 45,000 |
| Revenue | 12.7B USD (2022) |
Boston Scientific is a medical technology company. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 62 |
| Sector (Life Science) | 1 of 5 |
| Type (Add-on Acquisition) | 6 of 48 |
| State (California) | 4 of 25 |
| Country (United States) | 5 of 47 |
| Year (2002) | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2002-02-12 |
InFlow Dynamics
Munich, Germany InFlow Dynamics Ltd. produces and distributes coronary stent systems for removing arterial constriction. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2002-07-08 |
BEI Medical System
Teterboro, New Jersey, United States BEI designs, manufactures and markets less-invasive technology used by gynecologists to treat excessive uterine bleeding due to benign causes. BEI's major technology is the Hydro ThermAblator(R) (HTA) System, a less-invasive technology for global endometrial ablation, a procedure designed to eliminate the tissue (the endometrium) responsible for menstrual bleeding. The HTA System allows gynecologists to perform endometrial ablation under direct visualization on an outpatient basis under local anesthesia. More than 200,000 hysterectomies are performed each year in the U.S. for excessive uterine bleeding due to benign causes. |
Buy | $95M |
Montreux Equity Partners is a growth investment firm focused on investing in commercial stage companies with category leading products, technologies, and services. Montreux Equity Partners looks to invest $10 to $20 million in fast growing companies with $5 to $50 million in revenue. Montreux Equity Partners was formed in 1993 and is headquartered in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 24 |
| Sector (Life Science) | 1 of 9 |
| Type (Add-on Acquisition) | 3 of 15 |
| State (California) | 3 of 22 |
| Country (United States) | 3 of 24 |
| Year (2002) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2002-04-09 |
Paymap
San Francisco, California, United States Paymap, Inc. is a provider of an electronic payment products and services to financial institutions. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2003-01-01 |
Percutaneous Systems
Palo Alto, California, United States PercSys is focused on developing and commercializing devices that make endourologic kidney stone procedures easier, less traumatic, and more effective therapeutically. The company's current devices influence outcomes of minimally invasive procedures performed in the operating room, devices in the pipeline and clinical efforts expand the company's reach into external, and eventually in-office, stone intervention. PercSys is based in Palo Alto, California. |
Buy | - |
